Performance of transient elastography for the staging of liver fibrosis: A meta-analysis

被引:1185
作者
Friedrich-Rust, Mireen [2 ]
Ong, Mei-Fang [1 ]
Martens, Swantje [1 ]
Sarrazin, Christoph [2 ]
Bojunga, Joerg [2 ]
Zeuzem, Stefan [2 ]
Herrmann, Eva [1 ]
机构
[1] Univ Saarland, Fac Med, D-66421 Homburg, Germany
[2] JW Goethe Univ Hosp, Dept Internal Med, Frankfurt, Germany
关键词
D O I
10.1053/j.gastro.2008.01.034
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Transient elastography has been studied in a multitude of liver diseases for the staging of liver fibrosis with variable results. A meta-analysis was performed to assess the overall performance of transient elastography for the diagnosis of liver fibrosis and to analyze factors influencing the diagnostic accuracy. Methods: Literature databases and international conference abstracts were searched. Inclusion criteria were as follows: evaluation of transient elastography, liver biopsy as reference, and assessment of the area under the receiver operating characteristic curve (AUROC). The meta-analysis was performed using the random-effects model for the AUROC, summary receiver operating curve techniques, as well as meta-regression approaches. Results: Fifty studies were included in the analysis. The mean AUROC for the diagnosis of significant fibrosis, severe fibrosis, and cirrhosis were 0.84 (95% confidence interval [CI], 0.82-0.86), 0.89 (95% CI, 0.88-0.91), and 0.94 (95% CI, 0.93-0.95), respectively. For the diagnosis of significant fibrosis a significant reduction of heterogeneity of the AUROC was found when differentiating between the underlying liver diseases (P <.001). Other factors influencing the AUROC were the scoring system used and the country in which the study was performed. Age, body mass index, and biopsy quality did not have a significant effect on the AUROC. Conclusions: Transient elastography can be performed with excellent diagnostic accuracy and independent of the underlying liver disease for the diagnosis of cirrhosis. However, for the diagnosis of significant fibrosis, a high variation of the AUROC was found that is dependent on the underlying liver disease.
引用
收藏
页码:960 / 974
页数:15
相关论文
共 109 条
[1]  
Baldaia C, 2006, HEPATOLOGY, V44, p276A
[2]  
Barrault C, 2005, HEPATOLOGY, V42, p485A
[3]   Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection:: Assessment using transient elastometry and the role of HCV genotype [J].
Barreiro, P ;
Martín-Carbonero, L ;
Núñez, M ;
Rivas, P ;
Morente, A ;
Simarro, N ;
Labarga, P ;
González-Lahoz, J ;
Soriano, V .
CLINICAL INFECTIOUS DISEASES, 2006, 42 (07) :1032-1039
[4]  
Barreiro P, 2006, ANTIVIR THER, V11, P869
[5]   Fibroscan: instructions for use [J].
Beaugrand, M .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (04) :513-514
[6]   How to assess liver fibrosis and for what purpose? [J].
Beaugrand, M .
JOURNAL OF HEPATOLOGY, 2006, 44 (03) :444-445
[7]  
Beaugrand M, 2003, HEPATOLOGY, V38, p438A
[8]   Sampling variability of liver fibrosis in chronic hepatitis C [J].
Bedossa, P ;
Dargère, D ;
Paradis, V .
HEPATOLOGY, 2003, 38 (06) :1449-1457
[9]   Investigation of liver fibrosis in clinical practice [J].
Blanc, JF ;
Bioulac-Sage, P ;
Balabaud, C ;
Desmoulière, A .
HEPATOLOGY RESEARCH, 2005, 32 (01) :1-8
[10]   Liver stiffness in chronic hepatitis C: Will it modify the assessment of patients? [J].
Blanc, P. L. ;
Gabbuti, A. ;
Marino, N. ;
Mecocci, L. ;
Mazzotta, F. .
JOURNAL OF HEPATOLOGY, 2007, 46 :S201-S202